Caligan Partners Lp - Net Worth and Insider Trading

Caligan Partners Lp Net Worth

The estimated net worth of Caligan Partners Lp is at least $190 Million dollars as of 2024-11-05. Caligan Partners Lp is the 10% Owner of Alimera Sciences Inc and owns about 16,835,154 shares of Alimera Sciences Inc (ALIM) stock worth over $93 Million. Caligan Partners Lp is the Director, 10% Owner of Liquidia Corp and owns about 7,015,356 shares of Liquidia Corp (LQDA) stock worth over $72 Million. Caligan Partners Lp is also the 10% Owner of Standard BioTools Inc and owns about 11,444,836 shares of Standard BioTools Inc (LAB) stock worth over $24 Million. Details can be seen in Caligan Partners Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Caligan Partners Lp has not made any transactions after 2024-08-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Caligan Partners Lp

To

Caligan Partners Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Caligan Partners Lp owns 5 companies in total, including AMAG Pharmaceuticals Inc (AMAG) , Standard BioTools Inc (LAB) , and Liquidia Corp (LQDA) among others .

Click here to see the complete history of Caligan Partners Lp’s form 4 insider trades.

Insider Ownership Summary of Caligan Partners Lp

Ticker Comapny Transaction Date Type of Owner
AMAG AMAG Pharmaceuticals Inc 2019-08-12 10 percent owner
LAB Standard BioTools Inc 2022-08-04 10 percent owner
LQDA Liquidia Corp 2024-08-30 director & 10 percent owner & other: See Remarks
LIMIT LIMIT 2023-05-31 director & other: See Remarks
LIMIT LIMIT 2023-09-14 10 percent owner

Caligan Partners Lp Latest Holdings Summary

Caligan Partners Lp currently owns a total of 3 stocks. Among these stocks, Caligan Partners Lp owns 16,835,154 shares of Alimera Sciences Inc (ALIM) as of September 14, 2023, with a value of $93 Million and a weighting of 49.19%. Caligan Partners Lp owns 7,015,356 shares of Liquidia Corp (LQDA) as of August 30, 2024, with a value of $72 Million and a weighting of 37.92%. Caligan Partners Lp also owns 11,444,836 shares of Standard BioTools Inc (LAB) as of August 4, 2022, with a value of $24 Million and a weighting of 12.89%.

Latest Holdings of Caligan Partners Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALIM Alimera Sciences Inc 2023-09-14 16,835,154 5.54 93,266,753
LQDA Liquidia Corp 2024-08-30 7,015,356 10.25 71,907,399
LAB Standard BioTools Inc 2022-08-04 11,444,836 2.14 24,434,725

Holding Weightings of Caligan Partners Lp


Caligan Partners Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Caligan Partners Lp has made a total of 2 transactions in Alimera Sciences Inc (ALIM) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Alimera Sciences Inc is the sale of 579,000 shares on September 14, 2023, which brought Caligan Partners Lp around $2 Million.

According to the SEC Form 4 filings, Caligan Partners Lp has made a total of 7 transactions in Liquidia Corp (LQDA) over the past 5 years, including 6 buys and 1 sells. The most-recent trade in Liquidia Corp is the sale of 150,000 shares on August 30, 2024, which brought Caligan Partners Lp around $1 Million.

According to the SEC Form 4 filings, Caligan Partners Lp has made a total of 8 transactions in Standard BioTools Inc (LAB) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Standard BioTools Inc is the acquisition of 301,182 shares on August 4, 2022, which cost Caligan Partners Lp around $527,068.

Insider Trading History of Caligan Partners Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Caligan Partners Lp Trading Performance

GuruFocus tracks the stock performance after each of Caligan Partners Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Caligan Partners Lp is -5.01%. GuruFocus also compares Caligan Partners Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Caligan Partners Lp within 3 months outperforms 4 times out of 14 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Caligan Partners Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Caligan Partners Lp

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
9 out of 13 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.51 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.59 LIMIT LIMIT LIMIT LIMIT LIMIT

Caligan Partners Lp Ownership Network

Ownership Network List of Caligan Partners Lp

No Data

Ownership Network Relation of Caligan Partners Lp

Insider Network Chart

Caligan Partners Lp Owned Company Details

What does AMAG Pharmaceuticals Inc do?

Who are the key executives at AMAG Pharmaceuticals Inc?

Caligan Partners Lp is the 10 percent owner of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and Interim CFO Brian Piekos .

AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AMAG Pharmaceuticals Inc Insider Transactions

No Available Data

Caligan Partners Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Caligan Partners Lp. You might contact Caligan Partners Lp via mailing address: 515 Madison Avenue, 8th Floor, New York Ny 10022.